U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8064180641Clinical and Radiological Outcomes Study on Astra Tech Osseospeed Tx Profile ImplantEnrolling by invitationNo Results AvailableMalocclusion; Displaced or Missing Teethhttps://ClinicalTrials.gov/show/NCT01510470
8064280642Milnacipran for Chronic Pain in Knee OsteoarthritisCompletedHas ResultsKnee Osteoarthritis|Degenerative Joint Disease|Chronic PainDrug: Milnacipran|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01510457
8064380643Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: PROCHYMAL (remestemcel-L)https://ClinicalTrials.gov/show/NCT01510431
8064480644Socialization of Adult Men With Congenital Hemophilia A or BRecruitingNo Results AvailableHemophilia A|Hemophilia Bhttps://ClinicalTrials.gov/show/NCT01510418
8064580645Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon-Small Cell Lung CancerOther: Tissue Collectionhttps://ClinicalTrials.gov/show/NCT01510405
8064680646CEI Van Outreach Screening StudyActive, not recruitingNo Results AvailableGlaucoma|Macular Disease|KeratoconusDevice: OCT imaging, the FDA Cleared iVuehttps://ClinicalTrials.gov/show/NCT01510392
8064780647Reletex Versus Standard of Care Therapy for Post-Operative Nausea Control in Patients Undergoing Foregut SurgeryCompletedHas ResultsNausea and Vomiting Post-foregut SurgeryDevice: Reletex|Drug: IV ondansetron 4 mg q 6 hours for a total of 4 doses|Drug: IV promethazine 25 mg q 6 hours prn|Drug: Elixir promethazine 25 mg q 6 hours prn after dischargehttps://ClinicalTrials.gov/show/NCT01510379
8064880648The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)CompletedNo Results AvailablePoliomyelitisBiological: Inactivated Poliomyelitis Vaccine (Sabin strains)|Biological: Inactivated Poliomyelitis Vaccine (Salk strains)https://ClinicalTrials.gov/show/NCT01510366
8064980649Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac CatheterizationCompletedNo Results AvailableRadiation Monitoring|Radiation ProtectionDevice: Radiation monitoring devicehttps://ClinicalTrials.gov/show/NCT01510353
8065080650Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-managementNot yet recruitingNo Results AvailableHIVBehavioral: VIH-TAVIEhttps://ClinicalTrials.gov/show/NCT01510340
8065180651PLATINUM Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions-Pharmacokinetics (PLATINUM PK)Active, not recruitingHas ResultsCoronary Artery DiseaseDevice: PROMUS Element Everolimus-Eluting Coronary Stent System|Drug: Aspirin|Drug: Thienopyridinehttps://ClinicalTrials.gov/show/NCT01510327
8065280652Inflammatory Markers After COloRectal Surgery)CompletedNo Results AvailableInfectious Complications After Colorectal SurgeryBiological: C-reactive protein and procalcitonin dosageshttps://ClinicalTrials.gov/show/NCT01510314
8065380653Mobile Phone in Hypertension ManagementCompletedNo Results AvailableHypertensionDevice: Mobile phone-based self-report system, electronic Patient-Reported Outcomes Measure (e-PROM)https://ClinicalTrials.gov/show/NCT01510301
8065480654Phase 1 Trial of Ipilimumab and GVAX in Patients With Metastatic Castration-resistant Prostate CancerTerminatedNo Results AvailableProstate CancerDrug: GVAX and ipilimumabhttps://ClinicalTrials.gov/show/NCT01510288
8065580655Combined Use of Respiratory Devices After Thoracic SurgeryCompletedNo Results AvailableDyspnea|Well BeingDevice: Combined use of RESPIVOL® and RESPILIFT®|Device: Combined use of RESPIVOL® and RESPILIFT®https://ClinicalTrials.gov/show/NCT01510275
8065680656Repeat Sexually Transmitted Infection (STI) Patients: Tailored Socio-Contextual Intervention to Reduce HIV RiskNot yet recruitingNo Results AvailableSexually Transmitted Infection|HIVBehavioral: Tailored Socio-Contextual Intervention|Behavioral: Standard of Carehttps://ClinicalTrials.gov/show/NCT01510262
8065780657A Comparison of the Analgesic Efficacies of Ultrasound and Shock Wave Therapy in the Patients With Calcaneal SpurCompletedNo Results AvailableHeel Spurhttps://ClinicalTrials.gov/show/NCT01510249
8065880658Self-help Program Via Internet for Adolescents With CancerWithdrawnNo Results AvailableCancer|Depression|AnxietyBehavioral: Self-help programhttps://ClinicalTrials.gov/show/NCT01510236
8065980659The Effect of Macronutrients in the Diet on Digestive and Cardiovascular HealthCompletedNo Results AvailableObesity|Diabetes|Cardiovascular DiseasesDietary Supplement: Olive oil|Dietary Supplement: Olive oil and fish powder|Dietary Supplement: Olive oil and macadamia oil|Dietary Supplement: Deadaptationhttps://ClinicalTrials.gov/show/NCT01510223
8066080660Risk Profile for Patients With Atrial FibrillationRecruitingNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT01510210
8066180661Risk Profile for Atrial FibrillationCompletedNo Results AvailableAtrial Fibrillationhttps://ClinicalTrials.gov/show/NCT01510197
8066280662Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like TherapyTerminatedNo Results AvailableDiffuse Large B-cell Lymphoma|Follicle Center LymphomaDrug: Zevalin (ibritumomab tiuxetan)https://ClinicalTrials.gov/show/NCT01510184
8066380663Rapid Activity of Platelet Inhibitor Drugs StudyCompletedNo Results AvailableST-segment Elevation Myocardial InfarctionDrug: Prasugrel|Drug: Ticagrelorhttps://ClinicalTrials.gov/show/NCT01510171
8066480664Combining Lesinurad With Allopurinol in Inadequate RespondersCompletedNo Results AvailableGoutDrug: Lesinurad|Drug: Lesinurad|Drug: Placebo|Drug: Allopurinolhttps://ClinicalTrials.gov/show/NCT01510158
8066580665Efficacy of Changing to TRAVATAN® From Prior TherapyCompletedHas ResultsOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost 0.004% BAK-freehttps://ClinicalTrials.gov/show/NCT01510145
8066680666Travacom Post Marketing Surveillance StudyWithdrawnNo Results AvailableOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost/timolol fixed combination (Travacom)https://ClinicalTrials.gov/show/NCT01510132
8066780667Autophagy Inhibition to Augment mTOR Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine in Patients With Previously Treated Renal Cell CarcinomaRecruitingNo Results AvailableHistological Evidence of Metastatic Clear Cell Renal Cell Carcinoma|That Has Been Previously Treated With 1-3 Prior Regimens. Phase 1 Only, Any Number of Prior Regimens|With Evidence of Progressive Disease on or Within 6 Months|of Discontinuing Sunitinib,Drug: Hydroxychloroquine|Drug: RAD001https://ClinicalTrials.gov/show/NCT01510119
8066880668Ferric Citrate in Patients With End-Stage Renal Disease on DialysisCompletedNo Results AvailableESRD|Dialysis|HyperphosphatemiaDrug: Calcium acetate, sevelamer carbonate|Drug: Ferric citratehttps://ClinicalTrials.gov/show/NCT01510106
8066980669Diurnal Variation of Exogenous Peptides (Endogenous Insulin Jurgita II)CompletedNo Results AvailableType 2 Diabetes MellitusDrug: Insulin Aspart 100 IE/mlhttps://ClinicalTrials.gov/show/NCT01510093
8067080670Acceptance and Efficacy of Live SupervisionCompletedNo Results AvailableMental DisordersBehavioral: Computer-assisted live supervision|Behavioral: Delayed video-based supervisionhttps://ClinicalTrials.gov/show/NCT01510080

* Görseller ve İçerik tekif hakkına sahip olabilir